Top Markets
Coin of the day
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
Rankning i aktier #3185
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Aktiekurs
$10.35
Marknadsvärde
$6.19B
Förändring (1 dag)
3.79%
Förändring (1 år)
4.34%
Land
CN
Handel Gan & Lee Pharmaceuticals. (603087)

Kategori

Historik för aktiesplit för Gan & Lee Pharmaceuticals. (603087)
Aktien Gan & Lee Pharmaceuticals. (symbol: 603087) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 26, 2026.
En 603087-aktie köpt före Aug 26, 2026 motsvarar nu 0 603087-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH